New York, NY -- (SBWIRE) -- 02/01/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Forest Laboratories, Inc. (NYSE:FRX), GlaxoSmithKline plc (ADR) (NYSE:GSK), Exelixis, Inc. (NASDAQ:EXEL), HCA Holdings Inc (NYSE:HCA)
Forest Laboratories, Inc. (NYSE:FRX) trading on 2.67 million shares, to end the trade at $66.30. The stock changed hands in a range of $65.50 to $66.47, bringing its market capitalization to about $17.86 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $35.22 and was moved to the maximum level of $72.40. Forest Laboratories, Inc. (Forest) develops, manufactures and sells branded forms of ethical drug products, which requires a physician's prescription. The Company focuses on the development and introduction of new products, including products developed in collaboration with licensing partners.
Can Investors Bet on FRX after this News update? Find out in this Research Report
GlaxoSmithKline plc (ADR) (NYSE:GSK) declined -0.81%, to complete the trading session at $51.54, with a total volume of 2.69 million shares. The stock, on average, trades on a volume of 2.29 million shares. It floated in a range of $51.04 to $51.78 during the last trading session, with a beta value of 0.62. Its market capitalization now moved to about $126.50 billion. In the past 52 weeks, the share price has not declined below $43.68 and above $55.07. GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products.
Will GSK Get Buyers Even After The Recent Rally? Find Out Here
Exelixis, Inc. (NASDAQ:EXEL) recorded a fall of -1.99% and was in a range of $6.78-$7.02 before closing at $6.88. The stock completed the day with a total volume of 2.66 million shares, versus an average volume of 3.75 million shares. The share price hit its 52-week low of $4.32 and $8.41 was the best price. Exelixis, Inc. (Exelixis) is a biotechnology company engaged in developing small molecule therapies for the treatment of cancer. The Company is focusing its resources and development efforts on cabozantinib (XL184). It also has a portfolio of other compounds.
Will EXEL Bounce Back After yesterday’s Sharp Sell off? Find Out Here
HCA Holdings Inc (NYSE:HCA) added 1.58% yesterday, bringing its market capitalization around $22.51 billion. The share price, after opening at $48.85, made a high of $50.75 and hovered above $48.81 to end the day at $50.27. The total number of shares that changed hands during the session was 2.63 million shares, as compared to average trading volume of 2.77 million shares. HCA Holdings, Inc. (HCA) is a holding company whose affiliates owns and operates hospitals and related health care entities. HCA is a health care services companies in the United States. At December 31, 2011, it operated 163 hospitals, comprised of 157 general, acute care hospitals; five psychiatric hospitals, and one rehabilitation hospital. In addition, it operated 108 freestanding surgery centers.
What was the Moving Force behind HCA on Bullish Run? Read This Research Report
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)